Pancreatic Cancer Research

ResearcherUniversity of Central FloridaActive in the last 2 years

Deborah A. Altomare

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7014-0397; OpenAlex author ID A5054111631. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Dual Targeting of FGFR4 and PI3K-mTOR Suppresses Tumor-Associated Phenotypes in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/ijms27177722↗
  2. Induction of pancreatitis in mice with susceptibility to pancreatic cancer. Last author DOI 10.1016/bs.mcb.2021.12.013↗
  3. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal… Co-author DOI 10.1371/journal.pone.0265725↗
  4. Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer. Last author DOI 10.1021/acs.molpharmaceut.7b00718↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Joseph A. Goode · 1 shared paper, 2026 · strength 0.50
  2. Sarah B. Gitto · 2 shared papers, 2018–2022 · strength 0.29
  3. Otto Phanstiel · 2 shared papers, 2018–2022 · strength 0.23
  4. J. Pablo Arnoletti · 1 shared paper, 2022 · strength 0.14
  5. Sally A. Litherland · 1 shared paper, 2022 · strength 0.14
  6. Veethika Pandey · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.